Clinical trial
Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With…
NCT00061035 · Cosmo Bioscience, Industry · Completed
Key facts
| NCT number | NCT00061035 |
|---|---|
| Title | Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma |
| Official title | A Phase 1, Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma |
| Lead sponsor | Cosmo Bioscience, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms |
| Intervention type | Biological |
| Interventions | Transgenic Lymphocyte Immunization Vaccine (TLI) |
| Enrollment | 18 |
| Start date | Apr 1, 2003 |
| First posted | May 22, 2003 |
| Last update posted | Aug 28, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: